PRKCD and Alzheimer disease: Nevertheless, several previous reports have indicated that these pro-apoptotic mediators triggered by Aβs, including PKCδ, CDK5, and STAT3, may serve as potential biomarkers in plasma or cerebrospinal fluid (CSF) for AD in clinical settings.